Madrigal Pharmaceuticals (1MDGL.MI) Q2 2026 Earnings

6MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-4.42
-3.2
-1.98
-0.76

Details

Expected EPS
-3.599421087
Actual EPS
-2.7657499999999997
Surprise EPS
0.83
Surprise Percent
+23.16%

Description

Madrigal Pharmaceuticals (1MDGL.MI) has reported earnings of -2.7657499999999997 per share for Q2 2026.

0 Comments

Share your thoughts